A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease
Epistemonikos ID: 15f3c119c5e8b6bdc32d5f3835070d78f3323412
First added on: Aug 20, 2025